Related Experiment Video

Updated: Sep 11, 2025

Isolation of Atrial Cardiomyocytes from a Rat Model of Metabolic Syndrome-related Heart Failure with Preserved Ejection Fraction
08:31

Isolation of Atrial Cardiomyocytes from a Rat Model of Metabolic Syndrome-related Heart Failure with Preserved Ejection Fraction

Published on: July 26, 2018

10.3K

Atrial cardiomyopathy: current clinical perspectives and future insights

Moh'd Alamin Daise1, Geran Maule1, Mohamed Ismail1

  • 1Internal Medicine Program, UCF/HCA North Florida, Gainesville, FL, USA.

Future Cardiology
|August 14, 2025
PubMed

Insights

Atrial cardiomyopathy (ACM) involves complex atrial changes impacting heart function and increasing risks for stroke and heart failure. Standardized diagnosis and personalized treatments are crucial for better patient outcomes in this underrecognized condition.

Area of Science:

  • Cardiology
  • Cardiac Electrophysiology
  • Pathophysiology

Background:

  • Atrial cardiomyopathy (ACM) is characterized by structural, contractile, or electrophysiological atrial changes.
  • ACM lacks established diagnostic criteria and management guidelines, despite its role in arrhythmogenesis and heart failure progression.

Purpose of the Study:

  • To synthesize current knowledge on atrial cardiomyopathy.
  • To explore its pathophysiology, clinical relevance, and emerging diagnostic tools.
  • To advocate for standardized diagnostic frameworks and personalized treatment strategies.

Main Methods:

  • Literature review synthesizing current knowledge on ACM.
  • Exploration of pathophysiologic mechanisms including inflammation, oxidative stress, and genetic factors.
  • Discussion of clinical relevance in atrial fibrillation, ischemic stroke, and HFpEF.

Main Results:

  • ACM involves complex molecular, mechanical, and genetic factors leading to atrial remodeling.
  • Pathophysiology includes inflammation, oxidative stress, and genetic predisposition.
  • ACM is relevant in atrial fibrillation, ischemic stroke, and heart failure with preserved ejection fraction (HFpEF).

Conclusions:

  • Atrial cardiomyopathy is a significant clinical entity requiring further research.
  • Standardized diagnostic criteria and personalized treatment strategies are needed.
  • Improved understanding and management of ACM can enhance patient outcomes.

Keywords:
Atrial fibrillationatrial cardiomyopathyatriumcardiac rhythmcerebrovascular accidentfibrosisischemic stroke

More Related Videos

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples14:39

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

Published on: April 21, 2014

17.5K
Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

7.8K

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
53
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
33
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
48
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
31
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
40